June 2011 Latest Lung Updates from ASCO

Published: Thu Jun 23, 2011 Updated:Wed Sep 14, 2011

We would like to thank Dr Charles Butts for the latest lung updates.

 

PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC)

Erlotinib versus chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations: Interim results of the European Erlotinib Versus Chemotherapy (EURTAC) phase III randomized trial

 

 

 

Sign-up for Our E-Newsletter